Tomohiro Shimizu

Fosmidomycin, a specific inhibitor of 1-deoxy-d-xylulose 5-phosphate reductoisomerase in the nonmevalonate pathway for terpenoid biosynthesis

Tomohisa Kuzuyama, Tomohiro Shimizu, Shunji Takahashi et al. · Tetrahedron Letters · 1998 · 381 citations

Life Sciences, Biochemistry, Molecular Biology +14

Tertiary Structure-Function Analysis Reveals the Pathogenic Signaling Potentiation Mechanism of Helicobacter pylori Oncogenic Effector CagA

Takeru Hayashi, Miki Senda, Hiroko Morohashi et al. · Cell Host & Microbe · 2012 · 162 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +12

Siglec-15 Regulates Osteoclast Differentiation by Modulating RANKL-Induced Phosphatidylinositol 3-Kinase/Akt and Erk Pathways in Association With Signaling Adaptor DAP12

Yusuke Kameda, Masahiko Takahata, Miki Komatsu et al. · Journal of Bone and Mineral Research · 2013 · 128 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +17

Frequency of Teriparatide Administration Affects the Histological Pattern of Bone Formation in Young Adult Male Mice

Tomomaya Yamamoto, Tomoka Hasegawa, Muneteru Sasaki et al. · Endocrinology · 2016 · 72 citations · Full text

Medicine, Endocrinology, Pharmacology +17

Abnormal Biomechanics at 6 Months Are Associated With Cartilage Degeneration at 3 Years After Anterior Cruciate Ligament Reconstruction

Tomohiro Shimizu, Michael A. Samaan, Matthew S. Tanaka et al. · Arthroscopy The Journal of Arthroscopic and Related Surgery · 2018 · 70 citations · Full text

Medicine, Orthopaedic Surgery, Orthopedic Surgery +10